Multivariate Cox regression analysis demonstrated that positivity for CLEC10A is an independent prognostic marker for overall survival (hazard ratio: 0,45 (95% ci: 0,23 - 0,90; Fig. 7c) in addition to advanced stages of breast cancer disease. Here, CLEC10A is linked to breast carcinoma.